Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	67.13	119.17	16.64	68.14	103.11
Short-Term Investments	13.35	-	-	-	-
Cash & Short-Term Investments	80.48	119.17	16.64	68.14	103.11
Cash Growth	-32.46%	616.23%	-75.58%	-33.92%	7508.91%
Other Receivables	-	-	-	0.34	0.04
Receivables	-	-	-	0.34	0.04
Prepaid Expenses	1.59	1.51	0.8	0.2	0.12
Other Current Assets	-	-	0.07	2.33	0.85
Total Current Assets	82.08	120.67	17.51	71	104.12
Property, Plant & Equipment	1.81	2.26	2.77	3.08	3.59
Long-Term Deferred Charges	-	-	0.71	0.47	0.53
Other Long-Term Assets	0.45	0.73	0.1	0.1	0.05
Total Assets	84.34	123.65	21.09	74.64	108.28
Accounts Payable	0.65	1.55	2.47	2.76	0.84
Accrued Expenses	8.81	2.24	0.8	1.33	1.56
Short-Term Debt	-	-	0.11	-	-
Current Portion of Leases	0.56	0.55	0.49	0.43	0.37
Current Unearned Revenue	2.59	0.79	0.71	1.24	1.42
Total Current Liabilities	12.61	5.12	4.57	5.77	4.19
Long-Term Leases	0.95	1.57	2.12	2.61	3.35
Long-Term Unearned Revenue	0.39	2.67	2.32	1.56	2.49
Total Liabilities	13.95	9.37	9.01	9.93	10.03
Common Stock	0.03	0.03	0.01	0.01	0.18
Additional Paid-In Capital	481.96	474.44	342.89	336.28	315.6
Retained Earnings	-407.63	-356.21	-326.85	-267.6	-219.84
Treasury Stock	-3.97	-3.97	-3.97	-3.97	-3.97
Comprehensive Income & Other	0.01	-	-	-	-
Total Common Equity	70.39	114.29	12.08	64.72	91.97
Shareholders' Equity	70.39	114.29	12.08	64.72	98.25
Total Liabilities & Equity	84.34	123.65	21.09	74.64	108.28
Total Debt	1.51	2.12	2.71	3.04	3.72
Net Cash (Debt)	78.97	117.05	13.93	65.1	99.39
Net Cash Growth	-32.53%	740.43%	-78.61%	-34.50%	-
Net Cash Per Share	2.56	6.05	2.00	9.86	34.62
Filing Date Shares Outstanding	29.16	27.03	7.87	6.89	6.38
Total Common Shares Outstanding	29	27.03	7.31	6.88	6.02
Working Capital	69.46	115.55	12.93	65.23	99.93
Book Value Per Share	2.43	4.23	1.65	9.40	15.28
Tangible Book Value	70.39	114.29	12.08	64.72	91.97
Tangible Book Value Per Share	2.43	4.23	1.65	9.40	15.28
Machinery	1.6	1.48	1.49	1.45	1.29
Leasehold Improvements	0.22	0.21	0.21	0.21	0.21

Updated Jun 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q